BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 157 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $20,920,000 | +734.1% | 1,510,473 | +852.3% | 1.22% | +742.8% |
| Q2 2021 | $2,508,000 | -34.9% | 158,609 | -58.1% | 0.14% | -37.5% |
| Q1 2021 | $3,852,000 | -54.0% | 378,774 | -66.3% | 0.23% | -53.4% |
| Q4 2020 | $8,365,000 | +207.0% | 1,122,800 | +41.6% | 0.50% | +146.5% |
| Q3 2020 | $2,725,000 | -57.9% | 793,054 | -41.6% | 0.20% | -50.5% |
| Q2 2020 | $6,470,000 | +296.4% | 1,357,848 | +66.5% | 0.41% | +170.2% |
| Q1 2020 | $1,632,000 | -78.0% | 815,690 | -62.1% | 0.15% | -71.8% |
| Q4 2019 | $7,421,000 | +401.1% | 2,151,164 | +316.3% | 0.54% | +299.3% |
| Q3 2019 | $1,481,000 | -8.4% | 516,734 | +21.2% | 0.13% | -9.5% |
| Q2 2019 | $1,616,000 | – | 426,400 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |